| 摘要 |
The invention relates to pharmaceutical agents based on antiphlogistic active substances and to the use thereof in the treatment of diseases in the rheumatic sphere. The agents contain lactalbumin hydrolysate or a fraction thereof. Said hydrolysate allows smaller doses of the antiphlogistic agents to be administered than is conventionally required, to achieve a specific antiphlogistic effect. |
